It was announced today thatVicinitas Therapeutics, a biotechnology company advancing a proprietary targeted protein stabilization platform to develop novel therapeutics in cancer and genetic disorders, has launched with $65 million in Series A financing. The financing was co-led by a16z and...
Kevan Shokat photographed at UCSF. Photo by Noah Berger.
The UC San Francisco scientist who developed a successful approach to drugging a protein produced by the mutated KRAS gene has won two prestigious awards in the opening weeks of 2023. The discovery, made by Kevan Shokat, (...
Joint press release; UC Berkeley and Novartis Institutes for BioMedical Research
Illustration of DUBTAC in action against a target. (Courtesy Nomura Lab)
Novartis-Berkeley Translational Chemical Biology Institute combines Novartis expertise in chemical biology and medicinal chemistry with Berkeley’s expertise in covalent chemoproteomics and chemistry methodologies Research collaboration aims to unlock intractable drug targets, discover...
Researchers in the UC Berkeley lab of John Kuriyan have utilized powerful NSF funded supercomputers at the University of Texas Advanced Computing Center and the Pittsburgh Supercomputing Center to uncover the mechanism that activates cell mutations found in about 50 percent of melanomas.
Scientists have found that cancers in the pancreas (left) readily metastasize because these tumors suppress levels of an enzyme, MSRA, that pulls oxygen atoms off amino acids called methionine. As MSRA levels decrease, methionines on proteins become more oxidized. This causes one particular protein to rev up energy production in...
The Pew Charitable Trusts and the Alexander and Margaret Stewart Trust have announced the 2023 class of the Pew-Stewart Scholars Program for Cancer Research. Our congratulations goes to Assistant Professor of Chemistry and Chemical Biology, Ziyang Zhang who has been named one of five scholars this year.
